Personal information

head and neck cancers, drug discovery, adipose-derived stem cell, radiation-induced normal tissue injury, regenerative medicine, high throughput screening, genomic profiling
Canada

Activities

Employment (11)

University of Toronto: Toronto, ON, CA

2012 to present | Chair (Radiation Oncology)
Employment
Source: Self-asserted source
Fei-Fei Liu

University Health Network: Toronto, ON, CA

2012 to present | Head (Department of Radiation Oncology)
Employment
Source: Self-asserted source
Fei-Fei Liu

Princess Margaret Hospital Cancer Centre: Toronto, ON, CA

2012 to present | Chief (Radiation Medicine Program)
Employment
Source: Self-asserted source
Fei-Fei Liu

University of Toronto: Toronto, ON, CA

2002 to present | Professor (Otolaryngology)
Employment
Source: Self-asserted source
Fei-Fei Liu

University of Toronto: Toronto, ON, CA

2002 to present | Professor (Medical Biophysics)
Employment
Source: Self-asserted source
Fei-Fei Liu

University of Toronto: Toronto, ON, CA

2002 to present | Professor (Radiation Oncology)
Employment
Source: Self-asserted source
Fei-Fei Liu

Ontario Cancer Institute: Toronto, ON, CA

1992 to present | Senior Scientist
Employment
Source: Self-asserted source
Fei-Fei Liu

Princess Margaret Hospital Cancer Centre: Toronto, ON, CA

1988 to present | Staff Radiation Oncologist (Radiation Oncology)
Employment
Source: Self-asserted source
Fei-Fei Liu

Stanford University: Stanford, CA, US

1987 to 1988 | Hyperthermia Research Fellow (Stanford University Medical Center)
Employment
Source: Self-asserted source
Fei-Fei Liu

Princess Margaret Hospital Cancer Centre: Toronto, ON, CA

1983 to 1986 | Resident 4-6 (Radiation Oncology)
Employment
Source: Self-asserted source
Fei-Fei Liu

University of Toronto: Toronto, ON, CA

1980 to 1983 | Intern – R3 (Internal Medicine)
Employment
Source: Self-asserted source
Fei-Fei Liu

Education and qualifications (1)

University of Toronto: Toronto, ON, CA

1976 to 1980 | Medical Doctor (Faculty of Medicine)
Education
Source: Self-asserted source
Fei-Fei Liu

Professional activities (64)

Israel Cancer Research Fund: New York, New York, US

2019 to present | International Scientific Council (ISC)
Membership
Source: Self-asserted source
Fei-Fei Liu

University Health Network: Toronto, ON, CA

2018 to present | Chair (Medical Advisory Board)
Membership
Source: Self-asserted source
Fei-Fei Liu

University of Toronto Faculty of Medicine: Toronto, ON, CA

2017 to present (Governing Council and Academic Board)
Membership
Source: Self-asserted source
Fei-Fei Liu

University of Pennsylvania: Philadelphia, PA, US

2012 to present (Advisory Board; Research Training Program)
Membership
Source: Self-asserted source
Fei-Fei Liu

Chinese University of Hong Kong: New Territories, HK

2012 to present (Advisory Board)
Membership
Source: Self-asserted source
Fei-Fei Liu

University of Toronto: Toronto, ON, CA

2019 | Peter and Shelagh Godsoe Chair in Radiation Medicine
Distinction
Source: Self-asserted source
Fei-Fei Liu

University of Toronto: Toronto, ON, CA

2019 | Mel Silverman Mentorship Award
Distinction
Source: Self-asserted source
Fei-Fei Liu

American Society for Radiation Oncology: Arlington, VA, US

2019 | Fellow of ASTRO (FASTRO) Designation
Distinction
Source: Self-asserted source
Fei-Fei Liu

Israel Cancer Research Fund: New York, New York, US

2018 to 2018 | Chair (Translation Panel)
Membership
Source: Self-asserted source
Fei-Fei Liu

University of Hong Kong: Hong Kong, HK

2017 to 2018 | Co-Chair (Gordon Conference on Nasopharyngeal Carcinoma)
Membership
Source: Self-asserted source
Fei-Fei Liu

American Society for Radiation Oncology: VA, VA, US

2017 to 2018 (Finance/Audit Committee)
Membership
Source: Self-asserted source
Fei-Fei Liu

American Society for Radiation Oncology: Arlington, VA, US

2017 to 2017 | Basic/Translational Science Abstract Award, Sr. Investigator
Distinction
Source: Self-asserted source
Fei-Fei Liu

American Head and Neck Society: CA, CA, US

2016 to 2017
Membership
Source: Self-asserted source
Fei-Fei Liu

University Health Network: Toronto, ON, CA

2015 to 2017 | Co-Chair (Delegated Order Sets, Medical Acts Committee )
Membership
Source: Self-asserted source
Fei-Fei Liu

University Health Network: Toronto, ON, CA

2015 to 2017 | Medical Advisory Board (Vice Chair)
Membership
Source: Self-asserted source
Fei-Fei Liu

University of California San Francisco: San Francisco, CA, US

2016 to 2016 | Ted Phillips Distinguished Speaker
Distinction
Source: Self-asserted source
Fei-Fei Liu

Canada’s Fundamental Science Review: Canada, CA

2016 to 2016 | Invited Participant (Advisor Panel Roundtable)
Membership
Source: Self-asserted source
Fei-Fei Liu

Oak Ridge Associated Universities: Oak Ridge, TN, US

2015 to 2015 (Florida Department of Health’s Biomedical Research Programs)
Membership
Source: Self-asserted source
Fei-Fei Liu

10th Asia Pacific Multidisciplinary Meeting for Cancer Research: Asia, JP

2014 to 2014 | Dolly Huang Memorial Lecture
Distinction
Source: Self-asserted source
Fei-Fei Liu

Canadian Association of Radiation Oncology: Markham, Ontario, CA

2013 to 2013 | 2013 Best Abstract in Science and Applied Technology
Invited position
Source: Self-asserted source
Fei-Fei Liu

American Society for Radiation Oncology: VA, VA, US

2013 to 2013 | 2013 Best of ASTRO Award
Distinction
Source: Self-asserted source
Fei-Fei Liu

University of Toronto: Toronto, ON, CA

2012 to 2017 | Elia Chair in Head & Neck Cancer Research (Re-appointment)
Distinction
Source: Self-asserted source
Fei-Fei Liu

Women in Cancer Research: Canada, CA

2012 to 2012 | Focus on Science
Distinction
Source: Self-asserted source
Fei-Fei Liu

WinC: Toronto, Ontario, CA

2012 to 2012 | Successful Mentor
Distinction
Source: Self-asserted source
Fei-Fei Liu

Israel Cancer Research Fund: New York, New York, US

2012 to 2012 | Women of Action 2012
Distinction
Source: Self-asserted source
Fei-Fei Liu

Canadian Association of Radiation Oncology: Markham, Ontario, CA

2012 to 2012 | Gordon Richards Lecturer 2012
Distinction
Source: Self-asserted source
Fei-Fei Liu

University of Toronto Faculty of Medicine: Toronto, ON, CA

2008 to 2012 (Executive of UT-Department of Radiation Oncology)
Membership
Source: Self-asserted source
Fei-Fei Liu

University of Toronto Faculty of Medicine: Toronto, ON, CA

2008 to 2012 (Executive of the Medical Biophysics Graduate Division)
Membership
Source: Self-asserted source
Fei-Fei Liu

Ontario Cancer Institute: Toronto, ON, CA

2008 to 2012 (Appointments Committee)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute of Canada: Canada, CA

2006 to 2012 (Advisory Committee on Research (ACOR))
Membership
Source: Self-asserted source
Fei-Fei Liu

Princess Margaret Cancer Centre: Toronto, Ontario, CA

2011 to 2011 | Most Influential Research Publication
Distinction
Source: Self-asserted source
Fei-Fei Liu

University of Toronto Faculty of Medicine: Toronto, ON, CA

2008 to 2011 (Decanal Promotions Committee)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Institutes of Health: Bethesda, MD, US

2010 to 2010 (Head and Neck Steering Committee)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2010 to 2010 (Tumor Biology & Imaging (TB&I) Task Force)
Membership
Source: Self-asserted source
Fei-Fei Liu

Canadian Association of Radiation Oncology: Markham, Ontario, CA

2009 to 2009 | Award for Best Abstract in Science and Applied Technology
Distinction
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2005 to 2007 (Subcommittee D)
Membership
Source: Self-asserted source
Fei-Fei Liu

University of Toronto Faculty of Medicine: Toronto, ON, CA

2005 to 2005 | Chair (East-West Symposium on Nasopharyngeal Carcinoma 2005 Combined with the Wharton Day)
Membership
Source: Self-asserted source
Fei-Fei Liu

University of Toronto Faculty of Medicine: Toronto, ON, CA

2005 to 2005 | Chair (Breast Cancer Symposium 2005; Advances in Breast Cancer: Molecularly targeted therapies)
Membership
Source: Self-asserted source
Fei-Fei Liu

Canadian Cancer Society: Toronto, ON, CA

2004 to 2005 (Terry Fox Program Project Review Team)
Membership
Source: Self-asserted source
Fei-Fei Liu

University of Toronto Faculty of Medicine: Toronto, ON, CA

1994 to 2005 | Director (University of Toronto Fellowship Program)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Institutes of Health: Bethesda, MD, US

2003 to 2003 | Invited Participant (NIH-sponsored workshop on Radiology Education and Training)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2003 to 2003 (Special Emphasis Panel)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2003 to 2003 (US Site Visit Review of P01 Re-submission Henry Ford Health Sciences Center)
Membership
Source: Self-asserted source
Fei-Fei Liu

Canadian Breast Cancer Foundation: ON, ON, CA

2000 to 2003 | Chair (Professional Advisory Committee of the Ontario Chapter )
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2002 to 2002 (US Site Visit Review of MD Anderson Cancer Center)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2002 to 2002 (US TJU P01 Re-review)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2002 to 2002 (US Site Visit Team at Henry Ford Health Sciences Center)
Membership
Source: Self-asserted source
Fei-Fei Liu

University of Toronto: Toronto, ON, CA

2001 to 2017 | Elia Chair in Head & Neck Cancer Research
Distinction
Source: Self-asserted source
Fei-Fei Liu

North American Hyperthermia Society: Puerto Rico, PR

2001 to 2001 (Scientific Organizing Committee)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2001 to 2001 (US Site Visit Team at Thomas Jefferson University)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2001 to 2001 (US Site Visit Team at Georgetown University)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2001 to 2001 (Reporting Team to Parent Committee D)
Membership
Source: Self-asserted source
Fei-Fei Liu

National Cancer Institute: Bethesda, MD, US

2000 to 2000 (US Site Visit Team at Duke University)
Membership
Source: Self-asserted source
Fei-Fei Liu

9th International Conference for Cancer Gene Therapy: San Diego, US

2000 to 2000 | Vical Award for Most Innovative Abstract
Distinction
Source: Self-asserted source
Fei-Fei Liu

Canadian Breast Cancer Foundation: ON, ON, CA

1999 to 2000 | Vice Chair (MAC of the Ontario Chapter)
Membership
Source: Self-asserted source
Fei-Fei Liu

Canadian Breast Cancer Foundation: ON, ON, CA

1998 to 1999 (Medical Advisory Board of the Ontario Chapter )
Membership
Source: Self-asserted source
Fei-Fei Liu

University of Toronto Faculty of Medicine: Toronto, ON, CA

1997 to 1999 (Promotion Committee, Faculty of Pharmacy, Faculty of Medicine, Dept of Pharmaceutical Sciences)
Membership
Source: Self-asserted source
Fei-Fei Liu

Canadian Breast Cancer Foundation: ON, ON, CA

1995 to 1998 (Medical Advisory Board)
Membership
Source: Self-asserted source
Fei-Fei Liu

Princess Margaret Cancer Centre: Toronto, Ontario, CA

1992 to 1998 (In-Patient Care Sub-committee of the Medical Advisory Committee)
Membership
Source: Self-asserted source
Fei-Fei Liu

Stanford University: Stanford, CA, US

1987 to 1987 | Gordon E. Richards Fellowship
Distinction
Source: Self-asserted source
Fei-Fei Liu

University of Toronto: Toronto, ON, CA

1985 to 1985 | Teaching bursary
Distinction
Source: Self-asserted source
Fei-Fei Liu

Canadian Association of Radiation Oncology: Markham, Ontario, CA

1984 to 1984 | Second Prize, Radiation Oncology Congress Award Competition
Distinction
Source: Self-asserted source
Fei-Fei Liu

Dana Farber Cancer Institute: Boston, MA, US

1980 to 1980 | K.J.R. Wightman Award
Distinction
Source: Self-asserted source
Fei-Fei Liu

Toronto Western Hospital: Toronto, ON, CA

1977 to 1978 | Physicians’ Services Incorporated Scholarship
Distinction
Source: Self-asserted source
Fei-Fei Liu

Funding (50)

Developing an anti-fibrosis treatment to improve cancer survivorship

2019 to 2022 | Grant
Canadian Cancer Society (Canada, CA)
Source: Self-asserted source
Fei-Fei Liu

Molecular analyses of the protocadherin fat 2: a novel therapeutic target in head and neck cancers

2018-08-01 to 2021-07-31 | Grant
Canadian Cancer Society (Toronto, CA)
GRANT_NUMBER:

316a207869756d933ff409be646a8b48

Source: Self-asserted source
Fei-Fei Liu via DimensionsWizard

Seeking Molecular Signatures for Nasopharyngeal Carcinoma.

2017-01 to 2021-01 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

PMH-HKU-SZH Radiation Oncology High Level Medical Team “Sanming Project of Medicine in Shenzhen”

2017 to 2021 | Grant
Health and Family Planning Commission of Shenzhen Municipality (Shenzhen, CN)
Source: Self-asserted source
Fei-Fei Liu

PMH-HKU-SZH Radiation Oncology High Level Medical Team “Sanming Project of Medicine in Shenzhen”.

2017 to 2021 | Grant
Health and Family Planning Commission of Shenzhen Municipality (Shenzhen, CN)
Source: Self-asserted source
Fei-Fei Liu

Detection of Genomic Clonal Heterogeneity in Oral Cavity Squamous Cell Carcinoma.

2016-09 to 2017-08 | Grant
Radiation Medicine Program, Princess Margaret Cancer Centre. (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Seeking Molecular Signatures for Nasopharyngeal Carcinoma.

2016-07 to 2017-06 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Epigenetic reprogramming of radiation fibrosis using adipose-derived stromal cells.

2015-08 to 2017-07 | Grant
Canadian Cancer Society Research Institute (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Novel ultrasound-activated microbubble enhancement of radiation response: Optimization of response.

2013-10 to 2018-09 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Discovery and characterization of UROD inhibitors for cancer therapy.

2013-04 to 2016-03 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Developing a molecular signature for distant metastasis in soft-tissue sarcomas.

2012-07 to 2015-02 | Grant
Cancer Research Society (QC, QC, CA)
Source: Self-asserted source
Fei-Fei Liu

Post-menopausal women with luminal A breast cancer might not require radiotherapy.

2012-04 to 2014-03 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

The blood-brain-bone (3B) triad of radiation-induced fatigue.

2012-02 to 2015-01 | Grant
Canadian Cancer Society Research Institute (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Micro-RNA and mRNA expression profiling to predict outcome and characterize the cervix cancer microenvironment.

2011-10 to 2015-09 | Grant
Ontario Institute for Cancer Research (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

A systematic proteomic analysis strategy for biomarker discovery in head & neck cancer.

2011-10 to 2014-09 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Is the improvement in survival for HPV associated head and neck cancer due to the addition of chemotherapy to radiotherapy or to a more treatment-sensitive cancer?

2011-04 to 2015-03 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Small molecule inhibitors against a novel radio- and chemo-sensitizing target for human cancers.

2010-04 to 2013-03 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Targeting UROD as a novel anti-cancer therapeutic strategy.

2010-04 to 2011 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Research Excellence in Radiation Medicine for the 21st Century (EIRR21).

2009-04 to 2015-03 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Pre-clinical characterization of PF-00299804 in human head and neck squamous cancer

2009 to 2014 | Grant
Pfizer Pharmaceuticals (CAN, CAN, CA)
Source: Self-asserted source
Fei-Fei Liu

Developing and validating a predictive micro-RNA signature for node-negative breast cancer.

2008-09 to 2011-08 | Grant
Canadian Breast Cancer Foundation (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Developing a predictive gene set for HNSCC patients.

2008-04 to 2011-03 | Grant
Ontario Institute for Cancer Research (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Quest for the “stem cell” in nasopharyngeal carcinoma.

2007 to 2008 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

The role of micro-RNAs in human nasopharyngeal carcinoma.

2007 to 2008 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Developing a predictive micro-RNA profile for breast cancer.

2007 to 2007 | Grant
Canadian Breast Cancer Research Alliance (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Investigating the effect of Seliciclib in human nasopharyngeal carcinoma.

2006 to 2009 | Grant
Cyclocel Ltd. (EUR, EUR, GB)
Source: Self-asserted source
Fei-Fei Liu

HTS for identification of novel anti-cancer radiosensitizers.

2006 to 2007 | Grant
Ontario Institute for Cancer Research (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

The potential efficacy of combining GX-015 with radiation therapy for human nasopharyngeal carcinoma.

2005 to 2006 | Grant
Geminix Advanced Oncology Therapeutics (CAN, CAN, CA)
Source: Self-asserted source
Fei-Fei Liu

Funding for the East-West Symposium on Nasopharyngeal Carcinoma.

2005 to 2005 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Funding for the East-West Symposium on Nasopharyngeal Carcinoma.

2005 to 2005 | Grant
National Cancer Institute of Canada (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Local radiotherapy contributes to leukemia in breast cancer by recruitment of hematopoietic stem cells.

2005 to 2005 | Grant
Canadian Breast Cancer Research Alliance (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

The next generation of gene transfer therapy for human nasopharyngeal cancer.

2004 to 2008 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Research Excellence in Radiation Medicine for the 21st Century (EIRR21).

2003 to 2009 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

A novel EBV-targeted cytolytic gene therapy for human lymphoma Project #2.

2003 to 2006 | Grant
Terry Fox Program Project (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Innovative gene therapy approaches for nasopharyngeal carcinoma.

2003 to 2006 | Grant
Ontario Cancer Research Network (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Evaluation of potential efficacy of 5A1 in human nasopharyngeal carcinoma.

2003 to 2005 | Grant
Senesco Technologies Inc (US, US, US)
Source: Self-asserted source
Fei-Fei Liu

The kiss of death: exploitation of an endogenous virus in nasopharyngeal cancer therapy.

2001 to 2006 | Grant
Princess Margaret Cancer Foundation (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Development of novel gene transfer strategies for nasopharyngeal carcinoma.

2001 to 2004 | Grant
Canadian Institutes of Health Research (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

The potential role of PI(3)K and PKB as mediators of heat and radiation sensitivity in human breast cancer.

1999 to 1999 | Grant
Canadian Breast Cancer Foundation (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Prognostic value of novel pathologic markers in women with lymph node negative breast cancer.

1998 to 2001 | Grant
National Cancer Institute of Canada (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Therapeutic potential of gene transfer strategy in nasopharyngeal carcinoma.

1998 to 2001 | Grant
Medical Research Council Canada (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Pathologic factors in early stage breast cancer.

1997 to 1997 | Grant
Canadian Breast Cancer Foundation (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Relationship between intracellular pH regulation and thermosensitivity in vitro.

1995 to 1998 | Grant
National Cancer Institute of Canada (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

A randomized study evaluating hyperthermia plus radiation vs radiation alone in the management of chestwall recurrences from breast cancer.

1992 to 1992 | Grant
Canadian Breast Cancer Foundation (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Relationship between intracellular pH regulation and thermosensitivity in vitro.

1991 to 1995 | Grant
National Cancer Institute of Canada (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Feasibility of treating human tumours with hyperthermia and concomitant vascular occlusion.

1990 to 1993 | Grant
Medical Research Council Canada (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Relationship between intracellular pH regulation and thermosensitivity in vitro.

1990 to 1991 | Grant
National Cancer Institute of Canada (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Investigations of clinical hyperthermia.

1990 to 1990 | Grant
Princess Margaret Hospital Trust Fund (Toronto, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Relationship between intracellular pH regulation and thermosensitivity in vitro.

1989 to 1991 | Grant
National Cancer Institute of Canada (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Relationship between intracellular pH regulation and thermosensitivity in vitro.

1989 to 1989 | Grant
University of Toronto (ON, ON, CA)
Source: Self-asserted source
Fei-Fei Liu

Works (50 of 200)

Items per page:
Page 1 of 4

Development of a Collaboration Model between Two Cancer Centres to Maintain Patient Access to Radiation Therapy during the Replacement of a Sole CT Simulator at a Regional Cancer Centre

Journal of Medical Imaging and Radiation Sciences
2019 | Journal article
EID:

2-s2.0-85064249856

Contributors: Loudon, J.; Proctor, L.; Wenz, J.; Roussos, J.; Chaudhry, N.; Moseley, D.; Zhang, B.; Yeung, I.; Liu, F.-F.; Wells, W.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Personalizing post-treatment cancer care: A cross-sectional survey of the needs and preferences of well survivors of breast cancer

Current Oncology
2019 | Journal article
EID:

2-s2.0-85065532332

Contributors: Kwan, J.Y.Y.; Croke, J.; Panzarella, T.; Ubhi, K.; Fyles, A.; Koch, A.; Dinniwell, R.; Levin, W.; McCready, D.; Chung, C. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting

Head and Neck
2019 | Journal article
EID:

2-s2.0-85061028765

Contributors: Hall, S.F.; Griffiths, R.J.; O'Sullivan, B.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Truncated-correlation photothermal coherence tomography derivative imaging modality for small animal in vivo early tumor detection

Optics Letters
2019 | Journal article
EID:

2-s2.0-85060904731

Contributors: Zhang, H.; Tavakolian, P.; Sivagurunathan, K.; Mandelis, A.; Shi, W.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma

Oncogenesis
2018 | Journal article
EID:

2-s2.0-85047434803

Contributors: Bissey, P.-A.; Law, J.H.; Bruce, J.P.; Shi, W.; Renoult, A.; Chua, M.L.K.; Yip, K.W.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

hsa-miR-24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c-Myc/epithelial-mesenchymal transition axis

Oncology Reports
2018 | Journal article
EID:

2-s2.0-85054040903

Contributors: Su, B.; Xu, T.; Bruce, J.P.; Yip, K.W.; Zhang, N.; Huang, Z.; Zhang, G.; Liu, F.-F.; Liang, J.; Yang, H. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma

Cell Reports
2018 | Journal article
EID:

2-s2.0-85055137026

Contributors: Karamboulas, C.; Bruce, J.P.; Hope, A.J.; Meens, J.; Huang, S.H.; Erdmann, N.; Hyatt, E.; Pereira, K.; Goldstein, D.P.; Weinreb, I. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis

Nature Communications
2018 | Journal article
EID:

2-s2.0-85057610193

Contributors: Inoue, M.; Nakashima, R.; Enomoto, M.; Koike, Y.; Zhao, X.; Yip, K.; Huang, S.H.; Waldron, J.N.; Ikura, M.; Liu, F.-F. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Preclinical quantitative in-vivo assessment of skin tissue vascularity in radiation-induced fibrosis with optical coherence tomography

Journal of Biomedical Optics
2018 | Journal article
EID:

2-s2.0-85054889263

Contributors: Demidov, V.; Zhao, X.; Demidova, O.; Pang, H.Y.M.; Flueraru, C.; Liu, F.F.; Vitkina, I.A.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Proteomic Analysis of Cancer-Associated Fibroblasts Reveals a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma

Journal of Proteome Research
2018 | Journal article
EID:

2-s2.0-85046122096

Contributors: Principe, S.; Mejia-Guerrero, S.; Ignatchenko, V.; Sinha, A.; Ignatchenko, A.; Shi, W.; Pereira, K.; Su, S.; Huang, S.H.; O'Sullivan, B. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in HPV-related Oropharyngeal Carcinoma

International Journal of Radiation Oncology Biology Physics
2018 | Journal article
EID:

2-s2.0-85042587699

Contributors: Kwan, J.Y.Y.; Su, J.; Huang, S.H.; Ghoraie, L.S.; Xu, W.; Chan, B.; Yip, K.W.; Giuliani, M.; Bayley, A.; Kim, J. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Workshop report for cancer research: Defining the shades of Gy: Utilizing the biological consequences of radiotherapy in the development of new treatment approaches

Cancer Research
2018 | Journal article
EID:

2-s2.0-85047878922

Contributors: Ahmed, M.M.; Norman Coleman, C.; Mendonca, M.; Bentzen, S.; Vikram, B.; Seltzer, S.M.; Goodhead, D.; Obcemea, C.; Mohan, R.; Prise, K.M. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV 've Oropharynx cancer? A population-based study

British Journal of Cancer
2017 | Journal article
EID:

2-s2.0-85031020355

Contributors: Hall, S.F.; Liu, F.-F.; O'Sullivan, B.; Shi, W.; Rohland, S.; Griffiths, R.; Groome, P.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Directly Improving the Quality of Radiation Treatment Through Peer Review: A Cross-sectional Analysis of Cancer Centers Across a Provincial Cancer Program

International Journal of Radiation Oncology Biology Physics
2017 | Journal article
EID:

2-s2.0-85014037127

Contributors: Rouette, J.; Gutierrez, E.; O'Donnell, J.; Reddeman, L.; Hart, M.; Foxcroft, S.; Mitera, G.; Warde, P.; Brundage, M.D.; Czarnota, G. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Emotional Intelligence and Burnout in Academic Radiation Oncology Chairs

Journal of Healthcare Management
2017 | Journal article
EID:

2-s2.0-85040792771

Contributors: Holliday, E.B.; Bonner, J.A.; Formenti, S.C.; Hahn, S.M.; Kalnicki, S.; Liu, F.-F.; Movsas, B.; Fuller, C.D.; Thomas, C.R.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Erratum to: A bedr way of genomic interval processing [Source Code Biol Med. 11, (2016), (14)]

Source Code for Biology and Medicine
2017 | Journal article
EID:

2-s2.0-85008467911

Contributors: Haider, S.; Waggott, D.; Lalonde, E.; Fung, C.; Liu, F.-F.; Boutros, P.C.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Genomic biomarkers for precision radiation medicine

The Lancet Oncology
2017 | Journal article
EID:

2-s2.0-85018767872

Contributors: Bratman, S.V.; Milosevic, M.F.; Liu, F.-F.; Haibe-Kains, B.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

In Reply

JAMA Oncology
2017 | Journal article
EID:

2-s2.0-85017524642

Contributors: Bratman, S.V.; Waldron, J.N.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

MicroRNAs in extracellular vesicles: Potential cancer biomarkers

Journal of Human Genetics
2017 | Journal article
EID:

2-s2.0-85008627182

Contributors: Kinoshita, T.; Yip, K.W.; Spence, T.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Optimizing computed tomography simulation wait times in a busy radiation medicine program

Practical Radiation Oncology
2017 | Journal article
EID:

2-s2.0-84996565263

Contributors: Roussos, J.; Zahedi, P.; Spence, T.; Swanson, L.-A.; Li-Cheung, F.; Cops, F.; Darcy, P.; Chhin, V.; Moyo, E.; Warde, P. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Quantitative phase-filtered wavelength-modulated differential photoacoustic radar tumor hypoxia imaging toward early cancer detection

Journal of Biophotonics
2017 | Journal article
EID:

2-s2.0-84991627905

Contributors: Dovlo, E.; Lashkari, B.; soo Sean Choi, S.; Mandelis, A.; Shi, W.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Strategic planning in an academic radiation medicine program

Current Oncology
2017 | Journal article
EID:

2-s2.0-85038826540

Contributors: Hamilton, J.L.; Foxcroft, S.; Moyo, E.; Cooke-Lauder, J.; Spence, T.; Zahedi, P.; Bezjak, A.; Jaffray, D.; Lam, C.; Létourneau, D. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

The KRAS variant as a predictive biomarker of cetuximab response in head and neck cancer

JAMA Oncology
2017 | Journal article
EID:

2-s2.0-85020083873

Contributors: Bruce, J.P.; Xu, W.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

A bedr way of genomic interval processing

Source Code for Biology and Medicine
2016 | Journal article
EID:

2-s2.0-85006132121

Contributors: Haider, S.; Waggott, D.; Lalonde, E.; Fung, C.; Liu, F.F.; Boutros, P.C.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Bone morphogenetic protein 2 (BMP2) induces growth suppression and enhances chemosensitivity of human colon cancer cells

Cancer Cell International
2016 | Journal article
EID:

2-s2.0-84989352631

Contributors: Vishnubalaji, R.; Yue, S.; Alfayez, M.; Kassem, M.; Liu, F.-F.; Aldahmash, A.; Alajez, N.M.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Building a New Model of Care for Rapid Breast Radiotherapy Treatment Planning: Evaluation of the Advanced Practice Radiation Therapist in Cavity Delineation

Clinical Oncology
2016 | Journal article
EID:

2-s2.0-84994840436

Contributors: Lee, G.; Dinniwell, R.; Liu, F.F.; Fyles, A.; Han, K.; Conrad, T.; Levin, W.; Marshall, A.; Purdie, T.G.; Koch, C.A.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma

Head and Neck
2016 | Journal article
EID:

2-s2.0-84933073652

Contributors: Wang, J.R.; Habbous, S.; Espin-Garcia, O.; Chen, D.; Huang, S.H.; Simpson, C.; Xu, W.; Liu, F.-F.; Brown, D.H.; Gilbert, R.W. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

HPV associated head and neck cancer

Cancers
2016 | Journal article
EID:

2-s2.0-84982306187

Contributors: Spence, T.; Bruce, J.; Yip, K.W.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Human papillomavirus genotype association with survival in head and neck squamous cell carcinoma

JAMA Oncology
2016 | Journal article
EID:

2-s2.0-85010383429

Contributors: Bratman, S.V.; Bruce, J.P.; O'Sullivan, B.; Pugh, T.J.; Xu, W.; Yip, K.W.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1

Oncotarget
2016 | Journal article
EID:

2-s2.0-84978141477

Contributors: Vishnubalaji, R.; Hamam, R.; Yue, S.; Al-Obeed, O.; Kassem, M.; Liu, F.-F.; Aldahmash, A.; Alajez, N.M.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

MicroRNAs in nasopharyngeal carcinoma

Chinese Clinical Oncology
2016 | Journal article
EID:

2-s2.0-84965170116

Contributors: Spence, T.; Bruce, J.; Yip, K.W.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

MiR-449a promotes breast cancer progression by targeting CRIP2

Oncotarget
2016 | Journal article
EID:

2-s2.0-84975451836

Contributors: Shi, W.; Bruce, J.; Lee, M.; Yue, S.; Rowe, M.; Pintilie, M.; Kogo, R.; Bissey, P.-A.; Fyles, A.; Yip, K.W. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Omission of Breast Radiotherapy in Low-risk Luminal A Breast Cancer: Impact on Health Care Costs

Clinical Oncology
2016 | Journal article
EID:

2-s2.0-84964687247

Contributors: Han, K.; Yap, M.L.; Yong, J.H.E.; Mittmann, N.; Hoch, J.S.; Fyles, A.W.; Warde, P.; Gutierrez, E.; Lymberiou, T.; Foxcroft, S. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Socioeconomic status, human papillomavirus, and overall survival in head and neck squamous cell carcinomas in Toronto, Canada

Cancer Epidemiology
2016 | Journal article
EID:

2-s2.0-84960092483

Contributors: Chu, K.P.; Habbous, S.; Kuang, Q.; Boyd, K.; Mirshams, M.; Liu, F.-F.; Espin-Garcia, O.; Xu, W.; Goldstein, D.; Waldron, J. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

The complexity of microRNAs in human cancer

Journal of Radiation Research
2016 | Journal article
EID:

2-s2.0-84988615387

Contributors: Kwan, J.Y.Y.; Psarianos, P.; Bruce, J.P.; Yip, K.W.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Chromosomal instability as a prognostic marker in cervical cancer

BMC Cancer
2015 | Journal article
EID:

2-s2.0-84930209361

Contributors: How, C.; Bruce, J.; So, J.; Pintilie, M.; Haibe-Kains, B.; Hui, A.; Clarke, B.A.; Hedley, D.W.; Hill, R.P.; Milosevic, M. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Comprehensive genomic characterization of head and neck squamous cell carcinomas

Nature
2015 | Journal article
EID:

2-s2.0-84923197605

Contributors: Lawrence, M.S.; Sougnez, C.; Lichtenstein, L.; Cibulskis, K.; Lander, E.; Gabriel, S.B.; Getz, G.; Ally, A.; Balasundaram, M.; Birol, I. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Developing a prognostic micro-RNA signature for Human Cervical Carcinoma

PLoS ONE
2015 | Journal article
EID:

2-s2.0-84928137330

Contributors: How, C.; Pintilie, M.; Bruce, J.P.; Hui, A.B.Y.; Clarke, B.A.; Wong, P.; Yin, S.; Yan, R.; Waggott, D.; Boutros, P.C. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Identification of a low-risk luminal a breast cancer cohort that may not benefit from breast radiotherapy

Journal of Clinical Oncology
2015 | Journal article
EID:

2-s2.0-84937129359

Contributors: Liu, F.-F.; Shi, W.; Done, S.J.; Miller, N.; Pintilie, M.; Voduc, D.; Nielsen, T.O.; Nofech-Mozes, S.; Chang, M.C.; Whelan, T.J. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma

Oncotarget
2015 | Journal article
EID:

2-s2.0-84924274346

Contributors: Bruce, J.P.; Hui, A.B.Y.; Shi, W.; Perez-Ordonez, B.; Weinreb, I.; Xu, W.; Haibe-Kains, B.; Waggott, D.M.; Boutros, P.C.; O'Sullivan, B. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Nasopharyngeal cancer: Molecular landscape

Journal of Clinical Oncology
2015 | Journal article
EID:

2-s2.0-84944193218

Contributors: Bruce, J.P.; Yip, K.; Bratman, S.V.; Ito, E.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Novel insights into head and neck cancer using next-generation "Omic" technologies

Cancer Research
2015 | Journal article
EID:

2-s2.0-84964308624

Contributors: Sepiashvili, L.; Bruce, J.P.; Hui Huang, S.; O'Sullivan, B.; Liu, F.-F.; Kislinger, T.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Photoacoustic radar phase-filtered spatial resolution and co-registered ultrasound image enhancement for tumor detection

Biomedical Optics Express
2015 | Journal article
EID:

2-s2.0-84942366535

Contributors: Dovlo, E.; Lashkari, B.; Mandelis, A.; Shi, W.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Predictors of breast radiotherapy plan modifications: Quality assurance rounds in a large cancer centre

Radiotherapy and Oncology
2015 | Journal article
EID:

2-s2.0-84925070724

Contributors: Lymberiou, T.; Galuszka, S.; Lee, G.; Xu, W.; Fyles, A.; Su, S.; Purdie, T.G.; Catton, P.; Chung, C.; Dinniwell, R. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas

Oncotarget
2015 | Journal article
EID:

2-s2.0-84948808346

Contributors: Wong, P.; Hui, A.; Su, J.; Yue, S.; Haibe-Kains, B.; Gokgoz, N.; Xu, W.; Bruce, J.; Williams, J.; Catton, C. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status

Cancer
2015 | Journal article
EID:

2-s2.0-84922487903

Contributors: Huang, S.H.; Waldron, J.N.; Milosevic, M.; Shen, X.; Ringash, J.; Su, J.; Tong, L.; Perez-Ordonez, B.; Weinreb, I.; Bayley, A.J. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Raising the next generation of physician-scientists: The chairs' perspective

International Journal of Radiation Oncology Biology Physics
2015 | Journal article
EID:

2-s2.0-84929463060

Contributors: Formenti, S.C.; Bonner, J.F.; Hahn, S.M.; Lawrence, T.S.; Liu, F.-F.; Thomas, C.R.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Refining American joint committee on cancer/union for international cancer control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas

Journal of Clinical Oncology
2015 | Journal article
EID:

2-s2.0-84924871945

Contributors: Huang, S.H.; Xu, W.; Waldron, J.; Siu, L.; Shen, X.; Tong, L.; Ringash, J.; Bayley, A.; Kim, J.; Hope, A. et al.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

Society of chairs of academic radiation oncology programs-endorsed radiation oncology department review process

International Journal of Radiation Oncology Biology Physics
2015 | Journal article
EID:

2-s2.0-84930606466

Contributors: Thomas, C.R.; Bonner, J.A.; Hahn, S.M.; Lawrence, T.S.; Liu, F.-F.; Formenti, S.C.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier

The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer

Oncotarget
2015 | Journal article
EID:

2-s2.0-84921825261

Contributors: Kogo, R.; How, C.; Chaudary, N.; Bruce, J.; Shi, W.; Hill, R.P.; Zahedi, P.; Yip, K.W.; Liu, F.-F.
Source: Self-asserted source
Fei-Fei Liu via Scopus - Elsevier
Items per page:
Page 1 of 4